RECENT ADVANCES IN DRUGS TARGETING PROTEIN KINASES FOR CANCER THERAPY.

EXPLORING THE PROTEIN KINASE INHIBITORY ACTIVITY OF QUINAZOLINES AS ANTICANCER AGENTS: FDA-APPROVED DRUGS AND PROMISING REPORTED COMPOUNDS

1,2,4-Triazolo[1,5-a]pyrimidines as significant scaffold in drug discovery.

PIM KINASES INHIBITORS AND PYRIMIDINE-BASED ANTICANCER AGENTS

Imidazo- and pyrazolopyrimidine scaffolds as anticancer agents

HDAC as a cancer target: Various scaffolds based on HDAC inhibitors and an overview of their advances

Synthesis and characterization of a new spirooxindole grafted pyrrolidino/piperidine moiety

Design, Sequential Synthesis, Kinase Inhibitors Comparative Docking, MD Simulations, 99mTc-Coupling and In-Vivo Studies of Novel Pyrazolopyrimidine Derivatives

Synthesis, Molecular Modeling and Anticancer Activity of New Rescinnamine Derivatives as MMR-Inducers

Synthesis, anticancer properties, and molecular modeling of novel thiazolyl-pyrazolone derivatives conjugated with tetrahydronaphthalene as anticancer agents with potential VEGFR